Cargando…

TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression

BACKGROUND: T cell immunoglobulin-3 (TIM-3) has been established as a negative regulatory molecule and plays a critical role in immune tolerance. TIM-3 is upregulated in exhausted CD8(+) T cells in both chronic infection and tumor. However, the nature of TIM-3(+)CD4(+) T cells in the tumor microenvi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xin, Zhu, Yibei, Li, Gang, Huang, Haitao, Zhang, Guangbo, Wang, Fengming, Sun, Jing, Yang, Qianting, Zhang, Xueguang, Lu, Binfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281852/ https://www.ncbi.nlm.nih.gov/pubmed/22363469 http://dx.doi.org/10.1371/journal.pone.0030676

Ejemplares similares

T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells
por: Li, Gang, et al.
Publicado: (2013)

Tim-3 Expression Defines Regulatory T Cells in Human Tumors
por: Yan, Jing, et al.
Publicado: (2013)

Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
por: Yu, Muming, et al.
Publicado: (2017)

TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
por: Sakuishi, Kaori, et al.
Publicado: (2013)

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
por: Du, Wenwen, et al.
Publicado: (2017)

Transcriptional profiles during the differentiation and maturation of monocyte-derived dendritic cells, analyzed using focused microarrays
por: Zhong, Weixue, et al.
Publicado: (2009)

Regulatory B cells: TIM‐1, transplant tolerance, and rejection
por: Cherukuri, Aravind, et al.
Publicado: (2021)

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8(+) T Cells
por: Sun, Runzi, et al.
Publicado: (2021)

An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
por: Tang, Yichen, et al.
Publicado: (2014)

The effects of Tim-3 activation on T-cells in gastric cancer progression
por: Yu, Jiangtao, et al.
Publicado: (2019)

Circulating T Cells Exhibit Different TIM3/Galectin-9 Expression in Patients with Obesity and Obesity-Related Diabetes
por: Sun, Lili, et al.
Publicado: (2020)

TIM-Finder: A new method for identifying TIM-barrel proteins
por: Si, Jing-Na, et al.
Publicado: (2009)

Expression of Tim4 in Glioma and its Regulatory Role in LN-18 Glioma Cells
por: Li, Weiguo, et al.
Publicado: (2016)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2013)

Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion
por: Ye, Linsen, et al.
Publicado: (2018)

B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival
por: Zhang, Xiuqin, et al.
Publicado: (2017)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

Differential Requirement of Beclin 1 for Regulating the Balance of Naïve and Activated CD4(+) T Cells
por: Xia, Rui, et al.
Publicado: (2020)

Expression of Tim-3 in peripheral blood mononuclear cells and placental tissue in unexplained recurrent spontaneous abortion
por: Zhuang, Xuewei, et al.
Publicado: (2018)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

TREM-1(low) is a novel characteristic for tumor-associated macrophages in lung cancer
por: Zhang, Guangbo, et al.
Publicado: (2016)

Cancer cell intrinsic TIM-3 induces glioblastoma progression
por: Guo, Qing, et al.
Publicado: (2022)

On-tissue dataset-dependent MALDI-TIMS-MS(2) bioimaging
por: Heuckeroth, Steffen, et al.
Publicado: (2023)

Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
por: Liu, Jian-Feng, et al.
Publicado: (2018)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Mertk Interacts with Tim-4 to Enhance Tim-4-Mediated Efferocytosis
por: Moon, Byeongjin, et al.
Publicado: (2020)

Biomechanical characterization of TIM protein–mediated Ebola virus–host cell adhesion
por: Dragovich, Matthew A., et al.
Publicado: (2019)

IL-36β Promotes CD8(+) T Cell Activation and Antitumor Immune Responses by Activating mTORC1
por: Zhao, Xin, et al.
Publicado: (2019)

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
por: Yasinska, Inna M., et al.
Publicado: (2019)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

Interview with Tim Smith
por: Smith, Tim, et al.
Publicado: (2019)

Tim Berners-Lee
Publicado: (2004)

Come on, Sir Tim!
Publicado: (2009)

B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
por: Shi, Tongguo, et al.
Publicado: (2019)

TIM-3 expression in breast cancer
por: Burugu, Samantha, et al.
Publicado: (2018)

Association between interleukin-36γ and tumor progression in non-small cell lung cancer
por: Liu, Lin, et al.
Publicado: (2020)

Divergent Small Tim Homologues Are Associated with TbTim17 and Critical for the Biogenesis of TbTim17 Protein Complexes in Trypanosoma brucei
por: Smith, Joseph T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1g0giudb77c36jsjudlf9ipin1